Nektar Therapeutics | NKTR - Trade Creditors


Nektar Therapeutics reported $15.56M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Agios Pharmaceuticals USD 18.36M 1.2M Dec/2025
ALKERMES USD 107.95M 39.95M Dec/2025
Alterity Therapeutics Limited AUD 1.27M 1.81M Dec/2024
Amgen USD 20.89B 1.25B Dec/2025
Baxter International USD 999M 46M Dec/2025
BioCryst Pharmaceuticals USD 15.83M 10.26M Dec/2025
Biogen USD 432M 18.9M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Cara Therapeutics USD 2.42M 2.42M Jun/2025
Cipla INR 30.35B 1.98B Sep/2025
Dr.Reddys Laboratories INR 40.8B 548M Dec/2025
Eisai JPY 85.49B 4.76B Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Esperion Therapeutics USD 65.07M 12.44M Dec/2025
Exelixis USD 29.62M 4.27M Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Grifols EUR 987.75M 47.87M Dec/2025
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
Incyte USD 1.63B 1.46B Dec/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
Ironwood Pharmaceuticals USD 1.61M 224K Sep/2025
Karyopharm Therapeutics USD 5.39M 2.8M Sep/2025
MacroGenics USD 4.79M 1.15M Dec/2025
Merck USD 4.15B 102M Sep/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Neurocrine Biosciences USD 545.5M 425.6M Dec/2025
Novartis USD 4.46B 99M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sarepta Therapeutics USD 280.84M 186.83M Dec/2025
Takeda JPY 467.59B 28.61B Dec/2025
Teva Pharmaceutical Industries USD 2.53B 176M Dec/2025
Xencor USD 10.83M 1.75M Dec/2025